Generics in Medicaid increased in price and shifted to larger manufacturers amid 2022-2023 amphetamine shortage
{{output}}
Introduction: In late 2022, several manufacturers of immediate-release (IR) amphetamine-based stimulant drugs reported shortages to the FDA. Regulatory requirements for amphetamine and other controlled substances, such as manufac... ...
